Aurora Cannabis: 3 Under-the-Radar Numbers That Actually Matter When It Reports Q1 Results

Marijuana is liable to be one of the fastest-growing industries of the upcoming decade. Even if the pie-in-the-sky sales figures put forth by investment bank Stifel of $200 billion in annual sales by 2030 don't come to fruition, we'll likely see a fivefold to tenfold increase in legal worldwide weed revenue over the next decade.

Among the many pot stocks for investors to choose from, Aurora Cannabis (NYSE: ACB) is often touted as the industry favorite. Should you need proof of Aurora's popularity, it was crowned the most-held stock on millennial-dominated investing app Robinhood earlier this year.

There are a number of factors that attract investors to Aurora Cannabis. There's its leading marijuana production, its global reach, and its focus on high-margin medical marijuana patients. I'd also opine that its single-digit share price plays a role. Despite being a mid-cap company with 1 billion shares outstanding and a $3.7 billion valuation, the company's $3.58 share price looks aesthetically and psychologically appealing to retail investors.

Source Fool.com